Headlines

Cola Consumption May Increase Erlotinib Absorption in Patients Taking PPIs

Cola consumption resulted in a clinically relevant increase in the absorption of the kinase inhibitor erlotinib in patients also taking the proton pump inhibitor (PPI) esomeprazole, according to study data.

Proton Beam Therapy Treats Childhood Brain Cancer as Effectively as Standard Radiation

Treating medulloblastoma with proton beam therapy results in survival rates in line with other proton therapies, according to recent study data.

Risk of Ovarian Cancer Predicted With Fine-tuned Test

A recent study fine-tuned the popular Simple Rules ultrasound test for ovarian cancer.

More Precise Cancer Predictions Are the Goal of New Guidelines for Precision Medicine

Given to the importance of improved cancer predictors, the American Joint Committee on Cancer (AJCC) has established first-of-its-kind guidelines for the practice of precision medicine.

Nab-paclitaxel Increases Complete Response Rate in Invasive Breast Cancer

Replacing paclitaxel with nab-paclitaxel, followed by neoadjuvant epirubicin and cyclophosphamide, proved beneficial for patients with invasive breast cancer.

Understanding Participation Factors Related to Web- and Phone-based Tobacco Cessation Programs

Understanding Participation Factors Related to Web- and Phone-based Tobacco Cessation Programs

A recent study examined factors that impact patient preferences for web- and phone-based tobacco cessation programs.

Satisfaction With Navigators Associated With Satisfaction With Cancer-related Care

A new study has linked satisfaction with nurse navigators to satisfaction with cancer-related care.

Earlier and More Frequent Tanning Bed Use by Women Associated With Melanoma Incidence and Age at Diagnosis

Younger age at first use and more frequent use of indoor tanning beds are largely responsible for the steep increase in melanoma diagnoses in women younger than 40 years.

Novel Procedure Improves Staging of Lymph Nodes in Patients With Breast Cancer

Novel Procedure Improves Staging of Lymph Nodes in Patients With Breast Cancer

The accuracy of axillary staging and of pathologic evaluation of clinically node-positive breast cancer is improved by a new procedure, reducing the need for a more invasive procedure with debilitating complications.

Risk of Metabolic Syndrome Increased in Survivors of Childhood Cancer

Early cardiovascular events are a risk for survivors of childhood cancer, according to researchers who also advocate for a unified definition of pediatric metabolic syndrome.

Conference Coverage

Targeted Hormone-radiation Treatment Shows Promise in Midgut Neuroendocrine Tumors

Tumor growth may be substantially slowed by the novel therapy 177Lutetium-DOTATATE (Lutathera), according to early results from a phase III study of patients with previously treated, advanced midgut neuroendocrine tumors.

Reduced Toxicity, Similar Efficacy Achieved With Novel Regimen for Advanced Rectal Cancer

No difference in local efficacy was found between two treatment regimens for colorectal cancer: short-course (5-day) radiation followed by consolidation chemotherapy before surgery and standard 5-week chemoradiation.

Lethal Prostate Cancer Risk Lower With Regular Aspirin Use

The risk of lethal prostate cancer, but not of overall, high-grade, or advanced cancers, was reduced with regular aspirin use.

Low-income Breast Cancer Survivors Benefit From Personalized Survivorship Care Plans

Survivorship care plans led to improved outcomes in a randomized, controlled trial reported at the American Society of Clinical Oncology 2016 Cancer Survivorship Symposium.

Adolescent and Young-adult Survivors of Hodgkin Lymphoma May Not Adhere to Follow-up Recommendations

Within the first year posttreatment, more than half of Hodgkin lymphoma survivors did not receive all recommended care. However, 96% had their recommended oncology visits and 70% had the recommended laboratory tests within the first 5 years.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs